Clinical Trials Directory

Trials / Completed

CompletedNCT07474350

Valethamate Bromide Versus Hyoscine Butyl Bromide in Reducing Labour Duration Among Primigravida

Valethamate Bromide Versus Hyoscine Butyl Bromide in Reducing Labour Duration Among Primigravida: A Randomised Controlled Trial.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
165 (actual)
Sponsor
Federal Teaching Hospital Abakaliki · Other Government
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

Labour is a physiological process that enables the natural delivery of fetus, placenta and membranes after the age of viability. This study compared the efficacy of valethamate bromide and hyoscine butyl bromide in reducing labour duration among primigravid women at Alex Ekwueme Federal University Teaching Hospital, Abakaliki

Detailed description

Labour is a physiological process that enables the natural delivery of fetus, placenta and membranes after the age of viability. When labour is prolonged, it may defeat the whole essence of pregnancy as a result of poor outcome. Efforts have been made to prevent prolonged labour which includes the use of certain medications such as hyoscinebutyl bromide and valethamate bromide. However, there is paucity of studies comparing the effectiveness of both drugs, which could provide a better choice of reducing labour duration and its attendants' complications. AIM: This study compared the efficacy of valethamate bromide and hyoscine butyl bromide in reducing labour duration among primigravid women at Alex Ekwueme Federal University Teaching Hospital, Abakaliki. RESEARCH METHOD: This was a randomized controlled study where equal members of primigravid women at term were recruited and received 8 mg (2 ml) of valethamatebromide;20 mg (2 ml) of hyoscine butyl bromideand 2ml of sterile water. Either valethamate bromide 8mg, hyoscine butyl bromide20mg and no intervention (2 ml of sterile water) were given intravenously to the women who met the criteria. The data obtained were analyzed using statistical package for social science (SPSS) software (version 2022, Chicago II, USA). Categorical variables were presented as numbers and percentages while continuous variables were presented as mean and standard deviation (mean + 25D). Logistic regression was used where appropriate. A difference with a P value of ≤ 0.05 was taken to be statistically significant.

Conditions

Interventions

TypeNameDescription
DRUGValethamate BromideTwo ml (16mg) of valethamate bromide was given intravenously to the patient who has attained active phase labour parameters
DRUGHyoscine butylbromideTwo ml (40mg) of hyoscine butylbromide was given intravenously to the patient who has attained active phase labour parameters
OTHERSterile waterTwo ml of water was given intravenously to the patient who has attained active phase labour parameters

Timeline

Start date
2023-09-01
Primary completion
2024-01-23
Completion
2024-01-23
First posted
2026-03-16
Last updated
2026-03-16

Locations

1 site across 1 country: Nigeria

Source: ClinicalTrials.gov record NCT07474350. Inclusion in this directory is not an endorsement.